1. ASGE Standards of Practice Committee, Chandrasekhara V, Khashab MA, et al. Adverse events associated with ERCP. Gastrointest Endosc. 2017; 85:32–47.
2. Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: european society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy. 2020; 52:127–149.
3. Mine T, Morizane T, Kawaguchi Y, et al. Clinical practice guideline for post-ERCP pancreatitis. J Gastroenterol. 2017; 52:1013–1022.
4. Haraldsson E, Kylänpää L, Grönroos J, et al. Macroscopic appearance of the major duodenal papilla influences bile duct cannulation: a prospective multicenter study by the scandinavian association for digestive endoscopy study group for ERCP. Gastrointest Endosc. 2019; 90:957–963.
5. Berry R, Han JY, Tabibian JH. Difficult biliary cannulation: historical perspective, practical updates, and guide for the endoscopist. World J Gastrointest Endosc. 2019; 11:5–21.
6. Yue P, Zhu KX, Wang HP, et al. Clinical significance of different periampullary diverticulum classifications for endoscopic retrograde cholangiopancreatography cannulation. World J Gastroenterol. 2020; 26:2403–2415.
7. Keswani RN, Qumseya BJ, O’Dwyer LC, Wani S. Association between endoscopist and center endoscopic retrograde cholangiopancreatography volume with procedure success and adverse outcomes: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017; 15:1866–1875.e3.
8. Williams EJ, Ogollah R, Thomas P, et al. What predicts failed cannulation and therapy at ERCP? Results of a large-scale multicenter analysis. Endoscopy. 2012; 44:674–683.
9. Peng C, Nietert PJ, Cotton PB, Lackland DT, Romagnuolo J. Predicting native papilla biliary cannulation success using a multinational endoscopic retrograde cholangiopancreatography (ERCP) Quality Network. BMC Gastroenterol. 2013; 13:147.
10. Wang P, Li ZS, Liu F, et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol. 2009; 104:31–40.
11. Halttunen J, Meisner S, Aabakken L, et al. Difficult cannulation as defined by a prospective study of the scandinavian association for digestive endoscopy (SADE) in 907 ERCPs. Scand J Gastroenterol. 2014; 49:752–758.
12. Testoni PA, Mariani A, Aabakken L, et al. Papillary cannulation and sphincterotomy techniques at ERCP: european society of gastrointestinal endoscopy (ESGE) clinical guideline. Endoscopy. 2016; 48:657–683.
13. Saito H, Koga T, Sakaguchi M, et al. Post-endoscopic retrograde cholangiopancreatography pancreatitis in patients with asymptomatic common bile duct stones. J Gastroenterol Hepatol. 2019; 34:1153–1159.
14. Saito H, Sakaguchi M, Kadono Y, et al. Disease-based risk stratification of postendoscopic retrograde cholangiopancreatography pancreatitis for common bile duct stones. Dig Dis Sci. 2022; 67:305–314.
15. Balik E, Eren T, Keskin M, et al. Parameters that may be used for predicting failure during endoscopic retrograde cholangiopancreatography. J Oncol. 2013; 2013:201681.
16. Jowell PS, Baillie J, Branch MS, Affronti J, Browning CL, Bute BP. Quantitative assessment of procedural competence. A prospective study of training in endoscopic retrograde cholangiopancreatography. Ann Intern Med. 1996; 125:983–989.
17. ASGE Training Committee, Jorgensen J, Kubiliun N, et al. Endoscopic retrograde cholangiopancreatography (ERCP): core curriculum. Gastrointest Endosc. 2016; 83:279–289.
18. Haraldsson E, Lundell L, Swahn F, et al. Endoscopic classification of the papilla of Vater. Results of an inter- and intraobserver agreement study. United European Gastroenterol J. 2017; 5:504–510.
19. Kiriyama S, Kozaka K, Takada T, et al. Tokyo guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018; 25:17–30.
20. Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013; 48:452–458.
21. Fukatsu H, Kawamoto H, Kato H, et al. Evaluation of needle-knife precut papillotomy after unsuccessful biliary cannulation, especially with regard to postoperative anatomic factors. Surg Endosc. 2008; 22:717–723.
22. Chen PH, Tung CF, Peng YC, Yeh HZ, Chang CS, Chen CC. Duodenal major papilla morphology can affect biliary cannulation and complications during ERCP, an observational study. BMC Gastroenterol. 2020; 20:310.
23. Kim SB, Kim KH, Kim TN. Comparison of outcomes and complications of endoscopic common bile duct stone removal between asymptomatic and symptomatic patients. Dig Dis Sci. 2016; 61:1172–1177.
24. Saito H, Kakuma T, Kadono Y, et al. Increased risk and severity of ERCP-related complications associated with asymptomatic common bile duct stones. Endosc Int Open. 2017; 5:E809–E817.
25. Xu XD, Qian JQ, Dai JJ, Sun ZX. Endoscopic treatment for choledocholithiasis in asymptomatic patients. J Gastroenterol Hepatol. 2020; 35:165–169.
26. Xiao L, Geng C, Li X, Li Y, Wang C. Comparable safety of ERCP in symptomatic and asymptomatic patients with common bile duct stones: a propensity-matched analysis. Scand J Gastroenterol. 2021; 56:111–117.
27. Hakuta R, Hamada T, Nakai Y, et al. Natural history of asymptomatic bile duct stones and association of endoscopic treatment with clinical outcomes. J Gastroenterol. 2020; 55:78–85.
28. Frost JW, Kurup A, Shetty S, Fisher N. Does the presence of a trainee compromise success of biliary cannulation at ERCP? Endosc Int Open. 2017; 5:E559–E562.
29. Lee TH, Park SH. Optimal use of wire-assisted techniques and precut sphincterotomy. Clin Endosc. 2016; 49:467–474.
30. Lee YS, Cho CM, Cho KB, et al. Difficult biliary cannulation from the perspective of post-endoscopic retrograde cholangiopancreatography pancreatitis: identifying the optimal timing for the rescue cannulation technique. Gut Liver. 2021; 15:459–465.